ABSTRACT
Coagulase-negative Staphylococci, including Staphylococcus epidermidis, are common pathogens in orthopedic prosthesis infections. Operation and prolonged treatment with rifampicin in combination with another antibiotic is often required. Coagulase-negative Staph-ylococci are frequently multi-resistant, but resistance to vancomycin is rare in Sweden. Linezolid is an alternative, however it is only recommended for up to 4 weeks treatment due to risk of hematological side effects. We have successfully used prolonged treatment with linezolid and rifampicin in a patient suffering from a complicated prosthetic joint infection caused by a vancomycin resistant Staphyloccous epidermidis strain.
Subject(s)
Anti-Bacterial Agents , Prosthesis-Related Infections/drug therapy , Staphylococcal Infections/drug therapy , Staphylococcus epidermidis/drug effects , Vancomycin Resistance , Acetamides/administration & dosage , Acetamides/pharmacology , Acetamides/therapeutic use , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Humans , Knee Prosthesis/adverse effects , Linezolid , Male , Middle Aged , Oxazolidinones/administration & dosage , Oxazolidinones/pharmacology , Oxazolidinones/therapeutic use , Prosthesis-Related Infections/microbiology , Rifampin/administration & dosage , Rifampin/pharmacology , Rifampin/therapeutic use , Staphylococcus epidermidis/isolation & purification , Treatment Outcome , Vancomycin/administration & dosage , Vancomycin/pharmacology , Vancomycin/therapeutic useABSTRACT
Clostridium difficile-associated disease (CDAD) with frequent watery stools, sometimes with painful bowel movements, fever and sickness, is probably the major known cause of antibiotic-associated diarrhea and colitis, most probably depending on a disruption of the normal intestinal balance in the microbiome. In this study, we have inoculated a mixture of fecal microbes--as an enema--originating from a healthy Scandinavian middle-aged donor, regularly re-cultivated under strict anaerobic conditions for more than 10 years, to 32 patients. Twenty-two patients (69%) were durably cured. In those patients receiving the transplant by colonoscopy, four out of five were cured. To the best of our knowledge, this is the first time a fecal culture of microbes has retained the possibility for years to cure a substantial number of patients with CDAD.